Characteristics

All

(N = 45)

BCL-2

p-value

<10% (N = 8)

>10% (N = 37)

No.

(%)

No.

(%)

No.

(%)

Age (years)

Mean ± SD

56.31

± 12.3

52.62

± 12.83

57.10

± 12.12

0.298•

Median (Range)

54

(38 - 74)

45.50

(42 - 73)

54

(38 - 74)

≤60 years

25

(55.6%)

5

(20%)

20

(80%)

0.716

>60 years

20

(44.4%)

3

(15%)

17

(85%)

Sex

Male

26

(57.8%)

6

(23.1%)

20

(76.9%)

0.435

Female

19

(42.2%)

2

(10.5%)

17

(89.5%)

Rai classification

Stage 0, 1 & 2

20

(44.4%)

7

(35%)

13

(65%)

0.015

Stage 3 & 4

25

(55.6%)

1

(4%)

24

(96%)

Hepatomegally

Absent

23

(51.1%)

6

(26.1%)

17

(73.9%)

0.243

Present

22

(48.9%)

2

(9.1%)

20

(90.9%)

Lymphadenopathy

Absent

14

(31.1%)

3

(21.4%)

11

(78.6%)

0.689

Present

31

(68.9%)

5

(16.1%)

26

(83.9%)

Spleenomegally

Absent

12

(26.7%)

5

(41.7%)

7

(58.3%)

0.022

Present

33

(73.3%)

3

(9.1%)

30

(90.9%)

WBCs (×103/mm3)

Mean ± SD

46.80

±31.71

25.85

±8.49

51.33

±33.11

0.014•

Median (Range)

31.60

(17.50 - 122.80)

25

(17.50 - 38)

36

(17.50 - 122.80)

<100 × 103/mm3

39

(86.7%)

8

(20.5%)

31

(79.5%)

0.572

≥100 × 103/mm3

6

(13.3%)

0

(0%)

6

(100%)

Absolute lymphocytes (×103/mm3)

Mean ± SD

26.27

±16.42

17.01

±6.67

28.28

±17.25

0.085•

Median (Range)

18

(9.10 - 67)

17

(9.10 - 26)

19

(12.50 - 67)

<30 × 103/mm3

33

(73.3%)

8

(20.5%)

25

(75.8%)

0.087§

≥30 × 103/mm3

12

(26.7%)

0

(0%)

12

(100%)

Platelet count (×103/mm3)

Mean ± SD

121.13

±47.20

125

±46.94

120.29

±47.86

0.778•

Median (Range)

111

(45 - 205)

111

(76 - 200)

112

(45 - 205)

<100 × 103/mm3

19

(42.2%)

2

(10.5%)

17

(89.5%)

0.435§

≥100 × 103/mm3

26

(57.8%)

6

(23.1%)

20

(76.9%)

Hemoglobin (g/dl)

Mean ± SD

10.73

±2.29

11.73

±2.73

10.51

±2.17

0.191•

Median (Range)

10.20

(6.60 - 14.30)

12.65

(7 - 14.30)

10.10

(6.60 - 14)

<12 g/dl

25

(55.6%)

2

(8%)

23

(92%)

0.113

≥12 g/dl

20

(44.4%)

6

(30%)

14

(70%)